What happens to your body when you stop a GLP-1
In the STEP 1 trial extension, participants who had lost 17.3% of body weight on semaglutide regained 11.6 percentage points of it within a year of stopping, ending at 5.6% below where they started. That is roughly two thirds of the loss coming back. Appetite returns first, and a substantial share of what was lost was lean mass, which does not come back on its own.
This is the most searched and least honestly answered question in weight loss right now. Here is what the actual trial data shows, including the part nobody puts in the marketing.
The number
STEP 1 randomised 1,961 adults to 68 weeks of weekly semaglutide 2.4mg or placebo. Mean weight loss at week 68 was 17.3% on semaglutide against 2.0% on placebo.
Then treatment stopped, and a subset of 327 participants was followed for another year off the drug. By week 120:
- They had regained 11.6 percentage points of the weight lost
- Net loss from baseline was 5.6%
- Cardiometabolic improvements largely reverted alongside the weight
So of 17.3% lost, about 5.6% stayed. Roughly two thirds came back within twelve months.
That is not a failure of willpower and it is not unique to semaglutide. It is what happens when you remove a drug that was suppressing appetite: appetite comes back.
The part that is worse than the number
Weight regained after rapid loss does not come back in the same proportions it left.
Rapid weight loss without adequate protein and resistance training costs a meaningful fraction of lean mass. When the weight returns, it returns disproportionately as fat. Repeat that cycle and body composition ends up worse at the same body weight than when you started.
This is the mechanism behind a specific and very common experience: someone comes off, returns to their old weight, and finds they look and feel worse at that weight than they did the first time.
What people actually do about it
There is no trick here, and anyone selling you one is selling you something. What the evidence supports is unglamorous.
Protect lean mass while you are still on it, not after. This is the whole game and almost everyone gets the timing wrong. Resistance training two or three times a week and protein at the high end of recommendations, during the loss phase, changes what you have left when you stop.
Do not taper the habits at the same time as the drug. The trial withdrew semaglutide and the lifestyle intervention together. In practice, people who hold the training and protein through the transition do better than the trial subset, though that comparison is observational rather than randomised.
Expect appetite to return and plan for it. It is not a moral event. It is the drug leaving. Having a food environment set up before that happens matters more than resolving to resist it.
Weigh less often, measure more. Waist and how clothes fit track composition better than the scale does during a regain phase.
On the compounds themselves
Since this site does not pretend the category does not exist, here is the state of it stated plainly.
Retatrutide is a triple receptor agonist, acting at GLP-1, GIP and glucagon receptors, where semaglutide acts at GLP-1 alone and tirzepatide at GLP-1 and GIP. The glucagon arm is the addition, and the theoretical interest is in energy expenditure rather than appetite suppression alone. Phase 2 trial results published in 2023 reported larger mean weight reductions than earlier agents at 48 weeks.
What that does not tell you is anything about discontinuation. There is no published long-term withdrawal data on retatrutide comparable to the STEP 1 extension. A more effective drug during treatment does not imply a different regain curve after it, and it would be dishonest to suggest it does until someone runs that study.
These are research compounds. Nothing above is a recommendation, and the lean mass section is where the evidence actually is.
FAQ
How much weight do you regain after stopping semaglutide?
In the STEP 1 extension, participants regained 11.6 of the 17.3 percentage points lost within a year, ending 5.6% below baseline. About two thirds returned.
Do the health benefits go away too?
Cardiometabolic improvements largely reverted alongside the weight in the same extension analysis.
Can you keep the weight off after a GLP-1?
Some people do. The extension followed a subset in which the lifestyle intervention was withdrawn at the same time as the drug, which is not what most people do in practice.
Does stopping cause muscle loss?
Stopping does not, but rapid loss beforehand often costs lean mass, and the weight that returns is disproportionately fat. Resistance training during the loss phase is what changes this.
Is retatrutide different when you stop?
Unknown. There is no published long-term withdrawal data on retatrutide equivalent to the STEP 1 extension.
Sources
- Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022.
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021. Original STEP 1 results.
- Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity, a phase 2 trial. New England Journal of Medicine, 2023.
Get the next one
Get new pieces as they go up. No more than one email a month, and nothing sold to you.
Unsubscribe in one click. We never sell or share the list.